ETF Managers Group’s Lineage Cell Therapeutics LCTX Stock Holding History

ETF Managers Group’s Portfolio LCTX Stock Details LCTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$478K	Sell
2022 Q4	$414K	Buy
2022 Q3	$373K	Buy
2022 Q2	$491K	Buy
2022 Q1	$289K	Sell
2021 Q4	$519K	Buy